Abstract
Sixty-eight patients suffering from breast cancer, ovarian cancer, lymphoma or multiple myeloma were treated with high-dose chemotherapy and autologous stem cell transplantation. They underwent placement of a central venous port via the subclavian vein for delivery of chemotherapy and reinfusion of stem cells. All patients were followed prospectively for device-related and overall complications, comprising a total of 18 213 days in situ (median: 267 days, range: 90–480). One patient experienced a pneumothorax (1.4%) spontaneously resolved, as an acute toxicity. Two patients (2.8%, 0.1 episodes/1000 days of use) were forced to have the port removed due to infection, caused by Streptococcus mitis in one case, while the causative agent was not identified by laboratory tests in the second. The other 66 patients completed the therapeutic programme, including peripheral stem cell reinfusions and supportive care, such as i.v. antibiotics, antiemetics or fluid administration and blood sample collection, without additional complications. In conclusion, the use of totally implantable central venous access ports has resulted in good long-term access to central veins, in spite of the severe neutropenia and increased septic risk of this category of oncology patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biffi, R., Martinelli, G., Pozzi, S. et al. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device. Bone Marrow Transplant 24, 89–93 (1999). https://doi.org/10.1038/sj.bmt.1701822
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701822
Keywords
This article is cited by
-
“Not even my husband knows that I have this [breast cancer]”: survivors’ experiences in accessing, navigating and coping with treatment
Supportive Care in Cancer (2024)
-
A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute
International Journal of Clinical Oncology (2016)
-
Wie sollen Urologen venöse subkutane Portsysteme implantieren?
Der Urologe (2012)
-
Systematic review: malfunction of totally implantable venous access devices in cancer patients
Supportive Care in Cancer (2011)
-
Subclavian Vein Versus Arm Vein for Totally Implantable Central Venous Port for Patients with Head and Neck Cancer: A Retrospective Comparative Analysis
CardioVascular and Interventional Radiology (2011)